THE SKYE FELL AFTER MUTED INTERIM DATA
THE SKYE FELL AFTER MUTED INTERIM DATA
Skye Bioscience (NASDAQ: SKYE) released its Phase 2a results for its experimental obesity drug, nimacimab, and while the outcome for their drug candidate is mixed, the outcome for the stock was not–it lost 50%...
IS IT TIME TO LOOK AT THIS CANADIAN HOUSING STOCK
IS IT TIME TO LOOK AT THIS CANADIAN HOUSING STOCK
QUICK FACTS Trading Symbols: AEP Share Price Today: $0.80 Shares Outstanding: 70.3 million Market Capitalization: $56 million Cash: $5 million* Debt: $19 million Enterprise Value: $70 million THE CYCLE TURNS? Last year, I sold...
OVID – PHASE 1 TRIAL GOOD ENOUGH, CAPITAL RAISE DOES RAISE SOME QUESTIONS
OVID – PHASE 1 TRIAL GOOD ENOUGH, CAPITAL RAISE DOES RAISE SOME QUESTIONS
Ovid Therapeutics (OVID – NASDAQ) came out with their Phase 1 study results in OV329 targeting treatment resistant epilepsy on Friday. The stock was up – in pre-market the stock went as high as...
THE REAL SPARE CAPACITY
THE REAL SPARE CAPACITY
The talk of the town in the oil market is spare capacity. OPEC+ spare capacity. When OPEC+ met in September they surprised the market by deciding to continue to increase production. OPEC+ plans another...
Canary Gold–BRAZ-CSE / CNYGF-OTC
Canary Gold–BRAZ-CSE / CNYGF-OTC
The Massive, Simple, Scalable Gold Play You’ve Never Heard Of—Yet Unique ideas are rare in mining/mineral exploration. But Canary Gold (BRAZ-CSE/CNYGF-OTC) has one of the best I’ve heard in a long time. This idea...
THIS VACCINE ALTERNATIVE COULD BE A BIG WINNER INVIVYD (IVVD – NASD)
THIS VACCINE ALTERNATIVE COULD BE A BIG WINNER INVIVYD (IVVD – NASD)
In the US in 2024, Covid vaccine uptake was 23% among adults and 14% among children. That works out to 70-80 million people that received a Covid vaccine…YEARS after the pandemic. INVIVYD (IVVD-NASD) is...
THE ESG TRADE
THE ESG TRADE
THAT’S MAKING A BIG COMEBACK–BIO-METHANE, OR RNG ANAERGIA (ANRG – TSX) GREENLANE (GRN – TSXV) The ESG trade of 2020-2022 made a lot of us a lot of money–it was one of the...
OVID THERAPEUTICS JUMPS ON NEW RESEARCH (from The Street Not The Lab)
OVID THERAPEUTICS JUMPS ON NEW RESEARCH (from The Street Not The Lab)
On July 17, we profiled OVID Therapeutics at 40 cents– Source: Stockcharts.com I’m seeing my watchlist blow up with multiple biotech stocks showing 10%+ moves in a single day. On July 17, we profiled...
MY OH MY, HOW DID THIS NASDAQ COMPANY FALTER SO FAST???
MY OH MY, HOW DID THIS NASDAQ COMPANY FALTER SO FAST???
(AND WHY DIDN’T I FOLLOW MY TRADING RULES?) Myomo (MYO – NASDAQ) was one of our big winners in 2023 and 2024–going from 80 cents to $7–WOOHOO! They have the rights to a myo-electric...
WILL HOUSING STOCKS BE THE NEXT BIG WINNER?
WILL HOUSING STOCKS BE THE NEXT BIG WINNER?
I have a very out of consensus opinion. I think that at some point in the next couple of months, the market is going to catch on that the US housing industry is bottoming...